← Back to Analyst Consensus 
KZIA Buy
KAZIA THERAPEUTICS LTD
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 2 upgrades / ▼ 0 downgrades / 0 reiterations from 2 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Oct 20, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Sep 10, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Sep 1, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 13, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Jul 15, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 1, 2026 | BTIG | initiate | — → Buy | — | 52% |
| Jun 11, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Apr 15, 2026 | Laidlaw & Co. | initiate | — → Buy | — | 20% |
| Jan 28, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Dec 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Oct 2, 2025 | Maxim Group | maintain | Buy → Buy | $20 | 42% |
| Jul 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $13 | 44% |
| Jun 11, 2025 | Maxim Group | maintain | Buy → Buy | $15 | 42% |
| Feb 6, 2025 | Maxim Group | initiate | — → Buy | $3 | 42% |
| Jul 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $2 | 44% |
| Apr 11, 2023 | HC Wainwright & Co. | upgrade | Neutral → Buy | $2 | 44% |
| Aug 2, 2022 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Aug 2, 2022 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Oct 14, 2021 | Maxim Group | initiate | — → Buy | $18 | 42% |
| Jan 5, 2021 | HC Wainwright & Co. | initiate | — → Buy | $17 | 44% |
Price Target Trend
Jun 29, 2026 Latest: $29.67 Oct 25, 2026
EPS Estimates
0y $-0.01
Lo: $-0.02 Hi: $-0.01
2 analysts ▲1
+1q —
+1y $-0.01
Lo: $-0.02 Hi: $-0.01
2 analysts 0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days